Notice of Clinical Trial for Canine Intranasal Adenocarcinoma in the United States for FDA submission

  • 22/11/2023

Malignant Tumor Treatment Technologies Inc. is currently conducting a clinical trial targeting canine intranasal adenocarcinoma at universities and private veterinary hospitals in the United States for FDA submission. For more details, please refer to the following link: